Thursday, 4/7/2022

Presenter Information

Megan LongFollow

Loading...

Media is loading
 

University

Shawnee State University

Major

Biology

Student Type

Undergraduate Student

Presentation Types

Oral Presentation

Keywords:

Cancer MGT AML EGCG

Abstract

Acute myeloid leukemia (AML) is a deadly cancer of the bone marrow and blood. Cancerous myeloid cells can travel from the bone marrow into the bloodstream, causing overcrowding of the remaining functional cells. We have found that when AML cells are treated with matcha green tea (MGT), cell proliferation decreases. In THP-1 cells, the knockdown of circadian rhythm genes Bmal1 and CLOCK both lead to a decrease in cell viability. One of the polyphenols in MGT, epigallocatechin-3-gallate, has been linked to circadian rhythm by inhibiting the circadian protein CLOCK. This indicates that epigallocatechin-3-gallate might also target other circadian rhythm proteins that function within the same pathway, such as Bmal1. The aim of this study is to investigate the possible mechanisms of Bmal1, CLOCK, and EGCG in THP-1 cell death. The results from this study could provide a novel therapy needed to treat this deadly disease.

Human Subjects

no

Faculty Mentor Name

Jennifer Napper

Faculty Mentor Title

Professor of Biology

Faculty Mentor Academic Department

Natural Sciences

Share

COinS
 

The Effects of Epigallocatechin-3-gallate and Circadian Rhythm Genes in THP-1 Acute Myeloid Leukemia Cells

Acute myeloid leukemia (AML) is a deadly cancer of the bone marrow and blood. Cancerous myeloid cells can travel from the bone marrow into the bloodstream, causing overcrowding of the remaining functional cells. We have found that when AML cells are treated with matcha green tea (MGT), cell proliferation decreases. In THP-1 cells, the knockdown of circadian rhythm genes Bmal1 and CLOCK both lead to a decrease in cell viability. One of the polyphenols in MGT, epigallocatechin-3-gallate, has been linked to circadian rhythm by inhibiting the circadian protein CLOCK. This indicates that epigallocatechin-3-gallate might also target other circadian rhythm proteins that function within the same pathway, such as Bmal1. The aim of this study is to investigate the possible mechanisms of Bmal1, CLOCK, and EGCG in THP-1 cell death. The results from this study could provide a novel therapy needed to treat this deadly disease.